Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning

Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori, Nakao Iwata, Ken Inada, Jun-ichi Iga, Taro Kishi, Kiyoshi Fujita, Yuka Kikuchi, Toshiaki Shichijo, Hideaki Tabuse, Shotatsu Koretsune, Hiroshi Terada, Haruko Terada, Toshifumi Kishimoto, Yuichiro Tsutsumi, Kazutaka Ohi

Open source

DOI: 10.1186/s12888-024-06031-4
Published: 2024-09-05
Container: BMC Psychiatry
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12888-024-06031-4,
  title = {Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning},
  author = {Jun Ishigooka and Kazuyuki Nakagome and Tetsuro Ohmori and Nakao Iwata and Ken Inada and Jun-ichi Iga and Taro Kishi and Kiyoshi Fujita and Yuka Kikuchi and Toshiaki Shichijo and Hideaki Tabuse and Shotatsu Koretsune and Hiroshi Terada and Haruko Terada and Toshifumi Kishimoto and Yuichiro Tsutsumi and Kazutaka Ohi},
  year = {2024},
  journal = {BMC Psychiatry},
  doi = {10.1186/s12888-024-06031-4},
  url = {https://doi.org/10.1186/s12888-024-06031-4}
}

RIS

TY  - JOUR
TI  - Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning
AU  - Jun Ishigooka
AU  - Kazuyuki Nakagome
AU  - Tetsuro Ohmori
AU  - Nakao Iwata
AU  - Ken Inada
AU  - Jun-ichi Iga
AU  - Taro Kishi
AU  - Kiyoshi Fujita
AU  - Yuka Kikuchi
AU  - Toshiaki Shichijo
AU  - Hideaki Tabuse
AU  - Shotatsu Koretsune
AU  - Hiroshi Terada
AU  - Haruko Terada
AU  - Toshifumi Kishimoto
AU  - Yuichiro Tsutsumi
AU  - Kazutaka Ohi
PY  - 2024
JO  - BMC Psychiatry
DO  - 10.1186/s12888-024-06031-4
UR  - https://doi.org/10.1186/s12888-024-06031-4
ER  -

APA

Ishigooka, J., Nakagome, K., Ohmori, T., Iwata, N., Inada, K., Iga, J., Kishi, T., Fujita, K., Kikuchi, Y., Shichijo, T., Tabuse, H., Koretsune, S., Terada, H., Terada, H., Kishimoto, T., Tsutsumi, Y., & Ohi, K. (2024). Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning. BMC Psychiatry. https://doi.org/10.1186/s12888-024-06031-4

Source records

crossref · retrieved 2026-09-25T18:53:42.665Z